Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Clinical trial NCT06671938 · COMPLETED

Trial details

NCT number: NCT06671938
Sponsor: BioArctic AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Multiple System Atrophy

Start date: 2024-10-24
Primary completion: 2026-08-10
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.